Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Mayne Pharma
Manufacturing
Teva recalls fentanyl buccal tablets produced for Mayne Pharma
A labeling problem has forced Teva to recall 13 lots of fentanyl buccal tablets. Safety updates on the product insert were omitted, the FDA said.
Kevin Dunleavy
May 1, 2023 2:32pm
Dr. Reddy's takes over Mayne's US generics in $105M deal
Feb 27, 2023 11:43am
TherapeuticsMD to slash its entire workforce of 212 people
Dec 9, 2022 8:15am
Catalent snaps up CDMO Metrics and its NC plant for $475M
Aug 10, 2022 10:15am
Mayne Pharma debuts $80M solid dose plant in North Carolina
Apr 18, 2018 8:55am
Grocers take on generic drug industry in price-fixing suit
Jan 31, 2018 10:15am
